Positions

Overview

  • Dr. Jane Schwebke is a Professor of Medicine who also has a joint appointment in Epidemiology in the UAB School of Public Health and serves as Medical Director of the Jefferson County Department of Health STD Clinic.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Delay in Seeking Health Care Services after Onset of Urethritis Symptoms in Men 2019
    2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients 2019
    2019 Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: A randomized, single-blind, phase 2, controlled trial 2019
    2019 Association between vaginal washing and vaginal bacterial concentrations 2019
    2019 Identification and characterization of NanH2 and NanH3, enzymes responsible for sialidase activity in the vaginal bacterium Gardnerella vaginalis 2019
    2019 Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women 2019
    2018 Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial 2018
    2018 Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study 2018
    2018 Mycoplasma genitalium Infection in Kenyan and US Women 2018
    2018 Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms 2018
    2018 Diagnostic performance of a molecular test versus clinician assessment of vaginitis 2018
    2018 Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence among Men and Women Determined by Nucleic Acid Amplification Testing 2018
    2018 A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis 2018
    2018 In vitro study of the susceptibility of clinical isolates of trichomonas vaginalis to metronidazole and secnidazole 2018
    2018 Secnidazole: Next-generation antimicrobial agent for bacterial vaginosis treatment 2018
    2018 Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women 2018
    2018 A silent epidemic: The prevalence, incidence and persistence of mycoplasma genitalium among young, asymptomatic high-risk women in the United States 2018
    2018 Comparisons of vaginal flora patterns among sexual behaviour groups of women: Implications for the pathogenesis of bacterial vaginosis 2018
    2017 A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis 2017
    2017 Secnidazole Treatment of Bacterial Vaginosis 2017
    2017 Sexually transmitted infections: challenges ahead 2017
    2017 Clinical Validation of a Test for the Diagnosis of Vaginitis 2017
    2017 Meatal swabs contain less cellular material and are associated with a decrease in gram stain smear quality compared to urethral swabs in men 2017
    2017 Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women 2017
    2017 Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers 2017
    2016 Azithromycin treatment failure for chlamydia trachomatis among heterosexual men with nongonococcal urethritis 2016
    2016 Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses 2016
    2016 Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic 2016
    2016 Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections 2016
    2016 Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay 2016
    2016 Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases 2016
    2015 A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections 2015
    2015 Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections 2015
    2015 A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis 2015
    2015 Accuracy of self-report of sexual activity among adolescent girls: Implications for interpretation of vaginal flora patterns 2015
    2015 Randomized trial of periodic presumptive treatment with high-dose intravaginal metronidazole and miconazole to prevent vaginal infections in HIV-negative women 2015
    2015 Editorial commentary: Women who have sex with women: A unique population for studying the pathogenesis of bacterial vaginosis 2015
    2015 Management of Pelvic Inflammatory Disease in Selected US Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011 2015
    2014 Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic 2014
    2014 Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: A conceptual model 2014
    2014 Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system 2014
    2014 Association between BVAB1 and high Nugent scores among women with bacterial vaginosis 2014
    2014 ESwab as an optional collection device for use with the Affirm VPIII microbial test system 2014
    2014 Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: A mixed methods study 2014
    2014 Prevalence of Gardnerella vaginalis among women with lactobacillus- predominant vaginal flora 2014
    2014 Reply to hickey and forney 2014
    2014 Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure 2014
    2013 Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis 2013
    2013 Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis 2013
    2013 Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women 2013
    2013 Diagnostic rates differ on the basis of the number of read days with the use of the Inpouch culture system for Trichomonas Vaginalis screening 2013
    2013 Trichomonas vaginalis in selected US sexually transmitted disease clinics: Testing, screening, and prevalence 2013
    2013 Bacterial vaginosis among African American women who have sex with women 2013
    2013 Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis 2013
    2013 The clinical spectrum of Trichomonas vaginalis infection and challenges to management 2013
    2013 Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic 2013
    2013 Prevalence and treatment outcome of cervicitis of unknown etiology 2013
    2013 Gardnerella vaginalis: Still a prime suspect in the pathogenesis of bacterial vaginosis 2013
    2013 HIV testing among patients infected with neisseria gonorrhoeae: STD surveillance network, United States, 2009-2010 2013
    2012 Chlamydia trachomatis, mycoplasma genitalium, and trichomonas vaginalis infections in men with nongonococcal urethritis: Predictors and persistence after therapy 2012
    2012 Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis 2012
    2012 Retention of clinical trial participants in a study of Nongonococcal Urethritis (NGU), a sexually transmitted infection in men 2012
    2012 Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD surveillance network, 2009-2010 2012
    2012 Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests? 2012
    2012 Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships. 2012
    2012 HPV vaccine implementation in STD clinics-STD surveillance network 2012
    2011 Trichomonas vaginalis genital infections: Progress and challenges 2011
    2011 Molecular testing for Trichomonas vaginalis in women: Results from a prospective U.S. clinical trial 2011
    2011 Bacterial vaginosis is associated with variation in dietary indices 2011
    2011 Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic 2011
    2011 Re-evaluating the treatment of nongonococcal urethritis: Emphasizing emerging pathogens - A randomized clinical trial 2011
    2011 Tinidazole vs metronidazole for the treatment of bacterial vaginosis 2011
    2010 Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection 2010
    2010 Association between periodontal disease, bacterial vaginosis, and sexual risk behaviours 2010
    2010 A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women 2010
    2010 Race of male sex partners and occurrence of bacterial vaginosis 2010
    2010 Personal hygienic behaviors and bacterial vaginosis 2010
    2009 Bacterial vaginosis: Are we coming full circle? 2009
    2009 The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis 2009
    2009 New concepts in the etiology of bacterial vaginosis 2009
    2009 Prevalence of gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis 2009
    2009 Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women 2009
    2008 Partnership Concurrency Status and Condom Use Among Women Diagnosed with Trichomonas vaginalis 2008
    2008 Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium 2008
    2008 A longitudinal study of vaginal douching and bacterial vaginosis - A marginal structural modeling analysis 2008
    2008 Association of mobiluncus curtisii with recurrence of bacterial vaginosis 2008
    2008 Lactational amenorrhea as a risk factor for group a streptococcal vaginitis 2008
    2008 The polymicrobial hypothesis of bacterial vaginosis causation: A reassessment 2008
    2008 Trichomoniasis in a young girl: Nonsexual transmission is possible - But not likely 2008
    2008 Why Do Women Douche? A Longitudinal Study with Two Analytic Approaches 2008
    2007 Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age 2007
    2007 Natural history of asymptomatic bacterial vaginosis in a high-risk group of women 2007
    2007 The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women 2007
    2007 Dietary intake of selected nutrients affects bacterial vaginosis in women 2007
    2007 A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis 2007
    2007 A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases 2007
    2007 The Women's Health II Medical Education Network _Part 1: Understanding bacterial vaginosis: diagnosis, treatment, and improved outcomes. 2007
    2007 Trichomonas vaginalis infection in male sexual partners: Implications for diagnosis, treatment, and prevention 2007
    2006 Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole 2006
    2006 Methods for detection of Trichomonas vaginalis in the male partners of infected women: Implications for control of trichomoniasis 2006
    2006 A pilot study of vaginal flora changes with randomization to cessation of douching 2006
    2006 Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis 2006
    2006 Local and systemic cytokine levels in relation to changes in vaginal flora 2006
    2006 The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort 2006
    2005 Trichomoniasis in adolescents: A marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States 2005
    2005 Partner notification methods for African American men being treated for trichomoniasis: A consideration of main men, second hitters, and third players 2005
    2005 Association between genital tract cytomegalovirus infection and bacterial vaginosis 2005
    2005 Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases 2005
    2005 Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases 2005
    2005 Use of vaginal polymorphonuclear to epithelial cell ratios for the prediction of preterm birth 2005
    2005 Vulvovaginal symptoms in women with bacterial vaginosis 2005
    2004 Trichomoniasis 2004
    2004 Vaginal leucocyte counts in women with bacterial vaginosis: Relation to vagina and cervical infections 2004
    2004 Vulvovaginal symptoms in women with bacterial vaginosis 2004
    2004 Performance of a new, rapid assay for detection of Trichomonas vaginalis 2004
    2004 Predictors of bacterial vaginosis in adolescent women who douche 2004
    2004 Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic 2004
    2004 A Randomized, Double-Blind Clinical Trial of Vaginal Acidification versus Placebo for the Treatment of Symptomatic Bacterial Vaginosis 2004
    2003 High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: Implications for screening and urethritis management 2003
    2003 Gynecologic consequences of bacterial vaginosis 2003
    2002 Findings from STD screening of adolescents and adults entering corrections facilities: Implications for STD control strategies 2002
    2002 An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis 2002
    2002 Improved detection by DNA amplification of Trichomonas vaginalis in males 2002
    2002 Update of trichomoniasis 2002
    2002 Cost-effective screening for trichomoniasis [3] (multiple letters) 2002
    2002 Hepatitis, syphilis, and HIV sentinel surveillance in Mongolia 1999-2000 [2] 2002
    2002 Interrelationships of bacterial vaginosis and cervical inflammation 2002
    2002 Screening women in jails for chlamydial and gonococcal infection using urine tests feasibility, acceptability, prevalence, and treatment rates 2002
    2001 Antimicrobial resistance among neisseria gonorrhoeae isolates from Ulaanbaatar, Mongolia [5] 2001
    2001 Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections 2001
    2001 Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens 2001
    2001 Role of Vaginal Flora As a Barrier to HIV Acquisition. 2001
    2001 Influence of the normal menstrual cycle on vaginal microflora [6] 2001
    2001 Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth 2001
    2001 Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polymerase chain reaction 2001
    2000 Bacterial Vaginosis. 2000
    2000 Asymptomatic bacterial vaginosis: Response to therapy 2000
    2000 Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR 2000
    2000 Erratum: Mid-trimester vaginal biological markers of infection predictive of lower genital tract fetal fibronectin (FFN) (American Journal of Obstetrics and Gynecology (2000) 182 (1-2)) 2000
    2000 InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens 2000
    2000 Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility 2000
    2000 Screening for latent tuberculosis in sexually transmitted disease clinics [4] 2000
    1999 Correlation of behaviors with microbiological changes in vaginal flora 1999
    1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens 1999
    1999 High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers - Chicago, Birmingham, and San Francisco, 1998 1999
    1999 Viability of Trichomonas vaginalis in transport medium 1999
    1999 Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center 1999
    1999 Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis 1999
    1999 Self-reported sexual activity and condom use among symptomatic clients attending STD clinics 1999
    1998 Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities 1998
    1998 Sexually transmitted diseases in Ulaanbaatar, Mongolia 1998
    1998 Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea 1998
    1997 Effect of concurrent lower genital tract infections on cervical cancer screening 1997
    1997 Bacterial vaginosis - More questions than answers 1997
    1997 Bacterial vaginosis - More questions than answers 1997
    1997 Effect of concurrent lower genital tract infections on cervical cancer screening 1997
    1997 Self- treatment patterns among clients attending sexually transmitted disease clinics and the effect of self-treatment on STD symptom duration 1997
    1997 Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis 1997
    1997 Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic 1997
    1997 The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora 1997
    1996 Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains 1996
    1996 Humoral antibody to Mobiluncus curtisii, a potential serological marker for bacterial vaginosis 1996
    1996 Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. 1996
    1996 Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme 1996
    1996 Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme 1996
    1996 Tuberculosis screening in a sexually transmitted diseases clinic 1996
    1996 Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis 1996
    1995 Metronidazole: Utilization in the obstetric and gynecologic patient 1995
    1995 Pilot Study to Evaluate the Appropriate Management of Patients With Coexistent Bacterial Vaginosis and Cervicitis 1995
    1995 Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991 1995
    1994 Decreased susceptibility to penicillin G and tet M plasmids in genital and anorectal isolates of Neisseria meningitidis 1994
    1994 Prevalence and epidemiologic correlates of human t cell lymphotropic virus infection among intravenous drug users 1994
    1993 The validity of injecting drug users' self‐reports about sexually transmitted diseases: a comparison of survey and serological data 1993
    1992 Evaluation of syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens 1992
    1991 Use of a urine enzyme immunoassay as a diagnostic tool for chlamydia trachomatis urethritis in men 1991
    1991 Identification of two new antigenic subgroups within the genus Mobiluncus 1991
    1991 Risk for HIV infection among health care workers. Nine questions physicians often ask. 1991
    1990 Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women 1990
    1990 Demonstration of heterogeneity among the antigenic proteins of Mobiluncus species 1990
    1990 Pneumonia due to legionella micdadei in bone marrow transplant recipients 1990
    1990 Trends in sexually transmitted diseases in homosexually active men in king county, washington, 1980–1990 1990
    1987 Profile of the uremic neutrophil. 1987

    Chapter

    Year Title Altmetric
    2014 Trichomonas vaginalis.  3161-3164.e1. 2014
    2013 Vaginal Infections.  473-483. 2013

    Research Overview

  • Dr. Schwebke’s laboratory has emphasized microbiologic studies of vaginal flora in women including Trichomonas vaginalis and bacterial vaginosis (BV). Dr. Schwebke’s recent work has included the development of new methodologies for evaluation of changes in vaginal flora over time, new perspectives on the origins and management of women with BV, and evaluation of new diagnostic tests (culture methods, PCR) for trichomoniasis. She has also recently guided development of laboratory efforts to evaluate and carry out surveillance for nosocomial infections caused by resistant bacteria within UAB Hospital. Major ongoing research efforts include studies of interactions between BV and risk for other STDs; characterization of the make-up and shifts in normal vaginal flora in women; prevention of recurrent BV; and the epidemiology and optimal management strategies for trichomoniasis in males. Her research is funded through the UAB STD CRC (E.W. Hook, PI, J.R. Schwebke Co-PI); and 3 funded RO-1 grants (J.R. Schwebke, P.I.).
  • Principal Investigator On

  • Private Grant  awarded by MYCOVIA PHARMACEUTICAL, INC. 2018 - 2020
  • The UAB STI CRC - Project 2: Strain Diversity among Gardnerella: Association with Progression to BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Private Grant  awarded by SCYNEXIS 2019 - 2020
  • Randomized Controlled Trial of Treatment of Male Partners of Women with BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • The UAB Infectious Diseases Training Grant  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Slide Scoring in the Investigation between the Vaginal Microbiota and Uterine Fibroids  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2018
  • Private Grant  awarded by SCYNEXIS 2017 - 2018
  • Private Grant  awarded by CURATEK PHARMACEUTICALS 2015 - 2018
  • A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess The Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for The Treatment of Bacterial Vaginosis  awarded by Duke University 2018
  • Private Grant  awarded by GAGE DEVELOPMENT COMPANY, LLC 2017 - 2018
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2016 - 2017
  • Private Grant  awarded by STARPHARMA 2014 - 2017
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2017
  • Private Grant  awarded by BD DIAGNOSTICS 2015 - 2017
  • Private Grant  awarded by FLORA BIOSCIENCE 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2014 - 2016
  • Private Grant  awarded by VIAMET PHARMACEUTICALS, INC. - NEW 2014 - 2016
  • Private Grant  awarded by ELITECH GROUP MOLECULAR 2014 - 2016
  • Private Grant  awarded by QUIDEL CORPORATION 2015 - 2016
  • Private Grant  awarded by CEPHEID 2014 - 2016
  • Private Grant  awarded by ALFA-WASSERMAN, INC. 2015 - 2016
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by BIOHELIX CORPORATION 2013 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2014 - 2015
  • Private Grant  awarded by WATSON LABORATORIES, INC. 2014 - 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2014
  • Private Grant  awarded by CEPHEID 2013 - 2014
  • Private Grant  awarded by GEN-PROBE, INC. 2013 - 2014
  • Private Grant  awarded by CEPHEID 2014
  • Regional AIDS Education and Training Centers Program  awarded by Emory University 2010 - 2014
  • Regional AIDS Education and Training Centers Program  awarded by Emory University 2010 - 2014
  • RCT of Treatment of Male Partners of Women with Recurrent Bacterial Vaginosis  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2012 - 2014
  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-Formulated Pessaries vs Placebo for Preventing Vaginal Infection in HIV-Seronegative Women DMID# 09-0070  awarded by University of California, San Francisco 2012 - 2013
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2012 - 2013
  • Private Grant  awarded by COPAN DIAGNOSTICS, INC 2012 - 2013
  • Private Grant  awarded by EMBIL LLAC SANAYA LTD 2011 - 2013
  • UAB Infectious Diseases Training Grant  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2008 - 2013
  • Private Grant  awarded by MEDICIS PHARMACEUTICAL CORPORATION 2012 - 2013
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2013
  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-formulated Pessaries vs Placebo for Preventing Vaginal Infections in HIV-Seronegative Women DMID #09-0070  awarded by University of California, San Francisco 2010 - 2013
  • Private Grant  awarded by GEN-PROBE, INC. 2011 - 2012
  • Private Grant  awarded by METHYLGENE INC. 2011 - 2012
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2011 - 2012
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2011 - 2012
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2010 - 2011
  • Private Grant  awarded by BD DIAGNOSTICS 2010 - 2011
  • The Microbial Ecology of Bacterial Vaginosis: A Fine Scale Resolution Metagenomic Analysis  awarded by University of Maryland 2009 - 2011
  • Private Grant  awarded by GEN-PROBE, INC. 2009 - 2010
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2009 - 2010
  • Private Grant  awarded by SAVYON DIAGNOSTICS 2007 - 2010
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2008 - 2009
  • Investigator On

  • Private Grant  awarded by SPEEDX PTY. LTD. 2019 - 2023
  • Private Grant  awarded by LUPIN INC. 2019 - 2021
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T012 HHSN27200011 TA1 TO10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2020
  • Admin Core: Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200001 Task Area 1 Task Order 1 - Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200003 Task Area 2 Task Order 1 - Clinical Trial Implementation-DMID (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200008 Task Area 1 Task Order 8 - Protocol Development, Implementation and Analysis for A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200009 Task Area 1 Task Order 7 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200011 Task Area 1 Task Order 10 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200012 Task Area 1 Task Order 11 - Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Private Grant  awarded by NEUMODX MOLECULAR 2019 - 2020
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • The UAB STI CRC - DiSCIS Clinical Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Pathogenesis of Bacterial Vaginosis in Women Who Have Sex with Women  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Private Grant  awarded by SPEEDX PTY. LTD. 2018 - 2020
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2019 - 2020
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco 2018 - 2020
  • Private Grant  awarded by CEPHEID 2018 - 2019
  • Private Grant  awarded by RHEONIX, INC. 2014 - 2019
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2018 - 2019
  • Private Grant  awarded by ATLAS GENETICS 2017 - 2019
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by LUMINEX CORPORATION 2018 - 2019
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2017 - 2018
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2017 - 2018
  • Private Grant  awarded by ABBOTT MOLECULAR 2018
  • Private Grant  awarded by CLICK DIAGNOSTICS 2016 - 2018
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2016 - 2018
  • Trichomonas Vaginalis Repeat Infections Among HIV-Negative Women  awarded by TULANE UNIVERSITY 2013 - 2018
  • Private Grant  awarded by HOLOGIC, INC. 2017 - 2018
  • Private Grant  awarded by LUMINEX CORPORATION 2017
  • Private Grant  awarded by BECKMAN COULTER, INC. 2015 - 2017
  • Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2017
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2015 - 2016
  • Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings  awarded by University of California, San Francisco 2014 - 2015
  • JCDH Contract NO: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2014 - 2015
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2013 - 2015
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2004 - 2015
  • Private Grant  awarded by HOLOGIC, INC. 2014
  • STD/HIV Prevention Training Center  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION 2011 - 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2014
  • Private Grant  awarded by SANOFI PASTEUR LIMITED 2009 - 2013
  • Education And Training

  • Northwestern Memorial Hospital, Residency 1987
  • University of Washington Medical Center, Postdoctoral Fellowship 1989
  • Full Name

  • Jane Schwebke